Valuation: BICO Group AB

Market Cap 1.71B 173M 154M 142M 130M 244M 16.4B 248M 671M 8.56B 649M 635M 27.28B P/E 2026 *
-7.53x
P/E 2027 * -13.5x
Enterprise Value 1.64B 166M 147M 137M 124M 235M 15.74B 238M 644M 8.21B 622M 609M 26.18B EV / Sales 2026 *
1.01x
EV / Sales 2027 * 0.92x
Free-Float
69.88%
Yield 2026 *
-
Yield 2027 * -
1 day+39.45%
1 week+39.45%
Current month+39.45%
1 month+20.39%
3 months+91.65%
6 months+20.65%
Current year+27.24%
1 week 0.71
Extreme 0.7068
0.71
1 month 0.51
Extreme 0.506856
0.71
Current year 0.35
Extreme 0.35
0.71
1 year 0.35
Extreme 0.35
0.75
3 years 0.35
Extreme 0.35
1.55
5 years 0.35
Extreme 0.35
13.31
10 years 0.35
Extreme 0.35
14.8
Manager TitleAgeSince
Chief Executive Officer 51 01/09/2026
Director of Finance/CFO 56 01/03/2026
Chief Operating Officer - 07/01/2026
Director TitleAgeSince
Director/Board Member 71 18/12/2019
Director/Board Member 37 01/03/2015
Director/Board Member 51 07/05/2026
Change 5-day change 1-year change 3-year change Capi.($)
+39.45%+39.45% - - 173M
-0.93%+4.86%+28.03%+42.34% 255B
-1.06%+4.20%+9.56%+8.07% 161B
-0.27%+0.65%-4.36%+54.96% 151B
+0.57%+3.88%-55.27%-12.03% 64.33B
+1.47%+5.90%-13.25%-13.43% 51.9B
-0.85%+4.81%+9.39%+49.25% 50.25B
-1.70%+1.63%+16.02%+23.13% 49.92B
-1.47%+1.42%+21.88%+53.89% 48.77B
-1.62%+0.73%+30.59%+70.27% 42.93B
Average +3.36%+3.65%+4.73%+30.72% 97.22B
Weighted average by Cap. -0.68%+4.13%+8.51%+32.22%

Financials

2026 *2027 *
Net sales 1.62B 164M 146M 135M 123M 232M 15.54B 235M 636M 8.11B 615M 602M 25.86B 1.69B 170M 151M 140M 128M 241M 16.15B 245M 661M 8.43B 639M 625M 26.87B
Net income -227M -22.92M -20.37M -18.88M -17.18M -32.42M -2.18B -32.94M -89M -1.14B -86.02M -84.19M -3.62B -126M -12.72M -11.31M -10.48M -9.54M -18M -1.21B -18.29M -49.4M -630M -47.75M -46.73M -2.01B
Net Debt -69M -6.97M -6.19M -5.74M -5.22M -9.86M -661M -10.01M -27.05M -345M -26.15M -25.59M -1.1B -166M -16.76M -14.9M -13.81M -12.56M -23.71M -1.59B -24.09M -65.09M -830M -62.91M -61.57M -2.65B
Projected Income Statement - Annual - BICO Group AB
Logo BICO Group AB
BICO Group AB, previously Cellink AB is a Sweden-based company, which is primarily involved in the healthcare industry. The Company focuses on the application areas of bioprinting, multiomics, cell line development, and diagnostics. The Company develops and markets technologies that enable researchers in the life sciences to culture cells in 3D, perform high-throughput drug screening and print human tissues and organs for the medical, pharmaceutical, and cosmetic industries. The Company’s operations divided in two segments: The Industrial Solutions segment that offers products within precision dispensing and biosensor technology for industrial customers, which make a high-capacity contribution to customers production; and The Laboratory Solutions segment that offers 3Dprinters, single- cell and liquid- dispensing instruments as well as services and consumables related to these products.
Employees
554
Date Price Change Volume
Trader
Investor
Global
Quality
ESG MSCI
-
MarketScreener Ratings - BICO Group AB
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
24.25SEK
Average target price
29.00SEK
Spread / Average Target
+19.59%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - BICO Group AB